•  
  •  

Total Lymphoid Irradiation for Multiple Sclerosis

Total lymphoid irradiation uses radiation to limit the production of white blood cells (lymphocytes). These cells help the body's immune system destroy foreign cells and fight infection. The treatment was first developed to treat Hodgkin's lymphoma, a form of cancer.

In theory, total lymphoid irradiation may help prevent progression of multiple sclerosis (MS) by limiting the production of lymphocytes and thus limiting the activity of the immune system. The results of studies done so far have failed to show any benefit.

Total lymphoid irradiation remains an experimental treatment for MS. The treatment may be toxic and potentially dangerous and typically is not recommended.

Side effects of this treatment may include:

By Healthwise Staff
Primary Medical Reviewer Adam Husney, MD - Family Medicine
Primary Medical Reviewer Anne C. Poinier, MD - Internal Medicine
Specialist Medical Reviewer Barrie J. Hurwitz, MD - Neurology
Last Revised February 15, 2012

Last Revised: February 15, 2012

Author: Healthwise Staff

Medical Review: Adam Husney, MD - Family Medicine & Anne C. Poinier, MD - Internal Medicine & Barrie J. Hurwitz, MD - Neurology

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.